Hyperpolarization Induced by Lipopolysaccharides but Not by Chloroform Is Inhibited by Doxapram, an Inhibitor of Two-P-Domain K+ Channel (K2P)

被引:7
作者
Cooper, Robin L. [1 ]
Krall, Rebecca M. [2 ]
机构
[1] Univ Kentucky, Dept Biol, Lexington, KY 40506 USA
[2] Univ Kentucky, Dept STEM Educ, Lexington, KY 40506 USA
关键词
lipopolysaccharides; K2P channels; doxapram; Drosophila; chloroform; glutamate receptors; membrane potential; TOLL-LIKE RECEPTORS; DROSOPHILA-MELANOGASTER; POTASSIUM CHANNEL; SYNAPTIC-TRANSMISSION; IMMUNE-RESPONSE; CARBON-DIOXIDE; GENETIC MODEL; ANESTHETICS; TASK-3; PROTEINS;
D O I
10.3390/ijms232415787
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bacterial septicemia is commonly induced by Gram-negative bacteria. The immune response is triggered in part by the secretion of bacterial endotoxin lipopolysaccharide (LPS). LPS induces the subsequent release of inflammatory cytokines which can result in pathological conditions. There is no known blocker to the receptors of LPS. The Drosophila larval muscle is an amendable model to rapidly screen various compounds that affect membrane potential and synaptic transmission such as LPS. LPS induces a rapid hyperpolarization in the body wall muscles and depolarization of motor neurons. These actions are blocked by the compound doxapram (10 mM), which is known to inhibit a subtype of the two-P-domain K+ channel (K2P channels). However, the K2P channel blocker PK-THPP had no effect on the Drosophila larval muscle at 1 and 10 mM. These channels are activated by chloroform, which also induces a rapid hyperpolarization of these muscles, but the channels are not blocked by doxapram. Likewise, chloroform does not block the depolarization induced by doxapram. LPS blocks the postsynaptic glutamate receptors on Drosophila muscle. Pre-exposure to doxapram reduces the LPS block of these ionotropic glutamate receptors. Given that the larval Drosophila body wall muscles are depolarized by doxapram and hyperpolarized by chloroform, they offer a model to begin pharmacological profiling of the K2P subtype channels with the potential of identifying blockers for the receptors to mitigate the actions of the Gram-negative endotoxin LPS.
引用
收藏
页数:18
相关论文
共 45 条
  • [31] Developmental expression of a functional TASK-I 2P domain K+ channel in embryonic chick heart
    Zhang, Hengtao
    Parker, Jeremy
    Shepherd, Neal
    Creazzo, Tony L.
    JOURNAL OF BIOMEDICAL SCIENCE, 2009, 16
  • [32] Block of TREK and TRESK K2P channels by lamotrigine and two derivatives sipatrigine and CEN-092
    Walsh, Yvonne
    Leach, Michael
    Veale, Emma L.
    Mathie, Alistair
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2021, 26
  • [33] Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K+ Channel-Related Acid-Sensitive K+ Channel-1) (K2P3.1) K+ Channels Suppresses Atrial Fibrillation and Prevents Electrical Remodeling
    Schmidt, Constanze
    Wiedmann, Felix
    Beyersdorf, Christoph
    Zhao, Zhihan
    El-Battrawy, Ibrahim
    Lan, Huan
    Szabo, Gabor
    Li, Xin
    Lang, Siegfried
    Korkmaz-Icoz, Sevil
    Rapti, Kleopatra
    Jungmann, Andreas
    Ratte, Antonius
    Mueller, Oliver J.
    Karck, Matthias
    Seemann, Gunnar
    Akin, Ibrahim
    Borggrefe, Martin
    Zhou, Xiao-Bo
    Katus, Hugo A.
    Thomas, Dierk
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2019, 12 (09)
  • [34] Knockout of the gene encoding the K2P channel KCNK7 does not alter volatile anesthetic sensitivity
    Yost, C. Spencer
    Oh, Irene
    Il, Edmond I. Eger
    Sonner, James M.
    BEHAVIOURAL BRAIN RESEARCH, 2008, 193 (02) : 192 - 196
  • [35] Molecular identification of the dominant-negative, splicing isoform of the two-pore domain K+ channel K2P5.1 in lymphoid cells and enhancement of its expression by splicing inhibition
    Endo, Kyoko
    Kurokawa, Natsumi
    Kito, Hiroaki
    Nakakura, Sawa
    Fujii, Masanori
    Ohya, Susumu
    BIOCHEMICAL PHARMACOLOGY, 2015, 98 (03) : 440 - 452
  • [36] The hERG K+ channel S4 domain L532P mutation: Characterization at 37 °C
    Zhang, Yi H.
    Colenso, Charlotte K.
    Sessions, Richard B.
    Dempsey, Christopher E.
    Hancox, Jules C.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2011, 1808 (10): : 2477 - 2487
  • [37] Protein Kinase A Is Central for Forward Transport of Two-pore Domain Potassium Channels K2P3.1 and K2P9.1
    Mant, Alexandra
    Elliott, David
    Eyers, Patrick A.
    O'Kelly, Ita M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (16) : 14110 - 14119
  • [38] Expression and Prognostic Significance of the Oncogenic K2P Potassium Channel KCNK9 (TASK-3) in Ovarian Carcinoma
    Innamaa, Anni
    Jackson, Leigh
    Asher, Viren
    Van Shalkwyk, Gerhard
    Warren, Averil
    Hay, Daniel
    Bali, Anish
    Sowter, Heidi
    Khan, Raheela
    ANTICANCER RESEARCH, 2013, 33 (04) : 1401 - 1408
  • [39] Discovery of a Pharmacologically Active Antagonist of the Two-Pore-Domain Potassium Channel K2P9.1 (TASK-3)
    Coburn, Craig A.
    Luo, Yunfu
    Cui, Mingxiang
    Wang, Jiabing
    Soll, Richard
    Dong, Jingchao
    Hu, Bin
    Lyon, Michael A.
    Santarelli, Vincent P.
    Kraus, Richard L.
    Gregan, Yun
    Wang, Yi
    Fox, Steven V.
    Binns, Jacquelyn
    Doran, Scott M.
    Reiss, Duane R.
    Tannenbaum, Pamela L.
    Gotter, Anthony L.
    Meinke, Peter T.
    Renger, John J.
    CHEMMEDCHEM, 2012, 7 (01) : 123 - 133
  • [40] Heterodimerization of two pore domain K+ channel TASK1 and TALK2 in living heterologous expression systems
    Suzuki, Yoshiaki
    Tsutsumi, Kanako
    Miyamoto, Tatsuya
    Yamamura, Hisao
    Imaizumi, Yuji
    PLOS ONE, 2017, 12 (10):